Literature DB >> 26500063

The homeoprotein SIX1 controls cellular senescence through the regulation of p16INK4A and differentiation-related genes.

I Adrados1, J Larrasa-Alonso1, A Galarreta1, I López-Antona1, C Menéndez1, M Abad1, J Gil2, G Moreno-Bueno1,3, I Palmero1.   

Abstract

Cellular senescence is an antiproliferative response with essential functions in tumor suppression and tissue homeostasis. Here we show that SIX1, a member of the SIX family of homeobox transcriptional factors, is a novel repressor of senescence. Our data show that SIX1 is specifically downregulated in fibroblasts upon oncogenic stress and other pro-senescence stimuli, as well as in senescent skin premalignant lesions. Silencing of SIX1 in human fibroblasts suffices to trigger senescence, which is mediated by p16INK4A and lacks a canonical senescence-associated secretory phenotype. Interestingly, SIX1-associated senescence is further characterized by the expression of a set of development and differentiation-related genes that significantly overlap with genes associated with SIX1 in organogenesis or human tumors, and show coincident regulation in oncogene-induced senescence. Mechanistically, we show that gene regulation by SIX1 during senescence is mediated, at least in part, by cooperation with Polycomb repressive complexes. In summary, our results identify SIX1, a key development regulator altered in human tumors, as a critical repressor of cellular senescence, providing a novel connection between senescence, differentiation and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26500063      PMCID: PMC5730042          DOI: 10.1038/onc.2015.408

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  64 in total

Review 1.  The Eyes Absent proteins in development and disease.

Authors:  Emmanuel Tadjuidje; Rashmi S Hegde
Journal:  Cell Mol Life Sci       Date:  2012-09-13       Impact factor: 9.261

Review 2.  The EYA-SO/SIX complex in development and disease.

Authors:  Pin-Xian Xu
Journal:  Pediatr Nephrol       Date:  2012-07-19       Impact factor: 3.714

Review 3.  Chromatin repressive complexes in stem cells, development, and cancer.

Authors:  Anne Laugesen; Kristian Helin
Journal:  Cell Stem Cell       Date:  2014-06-05       Impact factor: 24.633

4.  Tumour biology: senescence in premalignant tumours.

Authors:  Manuel Collado; Jesús Gil; Alejo Efeyan; Carmen Guerra; Alberto J Schuhmacher; Marta Barradas; Alberto Benguría; Angel Zaballos; Juana M Flores; Mariano Barbacid; David Beach; Manuel Serrano
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

5.  Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.

Authors:  Ignacio Palmero; Matilde Murga; Ana Zubiaga; Manuel Serrano
Journal:  Oncogene       Date:  2002-05-02       Impact factor: 9.867

6.  Transcriptional differences between normal and glioma-derived glial progenitor cells identify a core set of dysregulated genes.

Authors:  Romane M Auvergne; Fraser J Sim; Su Wang; Devin Chandler-Militello; Jaclyn Burch; Yazan Al Fanek; Danielle Davis; Abdellatif Benraiss; Kevin Walter; Pragathi Achanta; Mahlon Johnson; Alfredo Quinones-Hinojosa; Sridaran Natesan; Heide L Ford; Steven A Goldman
Journal:  Cell Rep       Date:  2013-05-30       Impact factor: 9.423

7.  Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition.

Authors:  Erica L McCoy; Ritsuko Iwanaga; Paul Jedlicka; Nee-Shamo Abbey; Lewis A Chodosh; Karen A Heichman; Alana L Welm; Heide L Ford
Journal:  J Clin Invest       Date:  2009-08-24       Impact factor: 14.808

8.  Genome-wide maps of chromatin state in pluripotent and lineage-committed cells.

Authors:  Tarjei S Mikkelsen; Manching Ku; David B Jaffe; Biju Issac; Erez Lieberman; Georgia Giannoukos; Pablo Alvarez; William Brockman; Tae-Kyung Kim; Richard P Koche; William Lee; Eric Mendenhall; Aisling O'Donovan; Aviva Presser; Carsten Russ; Xiaohui Xie; Alexander Meissner; Marius Wernig; Rudolf Jaenisch; Chad Nusbaum; Eric S Lander; Bradley E Bernstein
Journal:  Nature       Date:  2007-07-01       Impact factor: 49.962

9.  Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.

Authors:  S M Farabaugh; D S Micalizzi; P Jedlicka; R Zhao; H L Ford
Journal:  Oncogene       Date:  2011-06-27       Impact factor: 9.867

10.  Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.

Authors:  Jean-Philippe Coppé; Christopher K Patil; Francis Rodier; Yu Sun; Denise P Muñoz; Joshua Goldstein; Peter S Nelson; Pierre-Yves Desprez; Judith Campisi
Journal:  PLoS Biol       Date:  2008-12-02       Impact factor: 8.029

View more
  4 in total

1.  Novel insights into a reputably irreversible process: combined mRNA and miRNA profiling of tissue from vesicourethral anastomotic stenosis after radical prostatectomy.

Authors:  T S Worst; K Daskalova; A Steidler; K Berner-Leischner; R Röth; B Niesler; C-A Weis; M C Kriegmair; P Erben; D Pfalzgraf
Journal:  World J Urol       Date:  2017-06-20       Impact factor: 4.226

2.  SIX1 represses senescence and promotes SOX2-mediated cellular plasticity during tumorigenesis.

Authors:  Cristina De Lope; Samara Martín-Alonso; Jaione Auzmendi-Iriarte; Carmen Escudero; Isabel Mulet; Javier Larrasa-Alonso; Irene López-Antona; Ander Matheu; Ignacio Palmero
Journal:  Sci Rep       Date:  2019-02-05       Impact factor: 4.379

3.  Dynamic regulation of myofibroblast phenotype in cellular senescence.

Authors:  Irene López-Antona; Constanza Contreras-Jurado; Laura Luque-Martín; Antonio Carpintero-Leyva; Paula González-Méndez; Ignacio Palmero
Journal:  Aging Cell       Date:  2022-03-09       Impact factor: 9.304

4.  Transcriptional regulation of CDKN2A/p16 by sirtuin 7 in senescence.

Authors:  Sergio Rodríguez; Litzy Gisella Bermúdez; Daniel González; Camila Bernal; Alejandra Cañas; Teresa Morales-Ruíz; Berta Henríquez; Adriana Rojas
Journal:  Mol Med Rep       Date:  2022-09-28       Impact factor: 3.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.